Antiretroviral therapy (ART) has substantially improved prognosis for people living with HIV (PLWH), but it does not eliminate integrated, transcriptionally silent proviruses that persist as latent HIV reservoirs. These reservoirs are the principal barrier to an HIV cure. The "Shock and Kill" approach aims to eradicate the reservoir by first reactivating latent proviruses with latency-reversing agents (LRAs) (the "shock"), followed by removal of the reactivated, infected cells (the "kill"). To date, most characterized LRAs provide reactivation without robustly eliminating reservoir cells, leaving the kill component unresolved.
To identify compounds with combined activities, the investigators screened a small-molecule library. From that screen they identified 2-hydrido-2,2'-spirobi(1,3,2-benzodioxaphosphole) (referred to as 2-HSB) as a novel candidate. According to the study abstract, 2-HSB shows two key properties relevant to Shock-and-Kill: it reactivates latent HIV-1 transcription and it selectively induces cytopathic effects in latently infected reservoir cell lines.
The principal finding reported is that a single small molecule, 2-HSB, can perform both components of the Shock-and-Kill paradigm in cell-line reservoir models. Specifically, 2-HSB reactivated latent provirus while preferentially triggering cytopathic effects in cell lines that harbor latent HIV. This dual-action profile distinguishes 2-HSB from most LRAs characterized to date, which typically provide only the reactivation ("shock") but not the selective elimination ("kill") of reservoir cells.
Mechanistic observations summarized in the abstract indicate the HIV-1 tat protein seems to play a role in the selective cytopathic effect of 2-HSB. The source states that tat appears to contribute to selectivity but does not provide detailed molecular pathways or comprehensive mechanistic data in the abstract. Further mechanistic work was recommended by the authors.
At the single-cell level, the two effects of 2-HSB—reactivation and induction of cytopathic effects—appeared largely independent under the experimental conditions used. In other words, reactivation of latent provirus was not simply a downstream result of cell death, and cell death was not merely a consequence of reactivation. This independence suggests separate or at least partially separable processes underpinning each observed activity of 2-HSB in the tested models.
Importantly, 2-HSB was active beyond reservoir-derived cell lines: the compound induced viral transcription in ex vivo CD4+ T cells obtained from ART-suppressed PLWH. This demonstrates that 2-HSB can stimulate HIV-1 transcription in primary cells from individuals on suppressive ART, an essential step toward translational relevance. The abstract does not supply quantitative details of induction magnitude, sample size, donor characteristics, or toxicity in primary cells; those experimental specifics were not reported in the provided source material.
The authors conclude that 2-HSB is a promising dual-action candidate that both reactivates latent HIV-1 and preferentially induces cytopathic effects in reservoir cell-line models. They emphasize the need for further mechanistic elucidation of how tat contributes to selectivity and for extended ex vivo validation in primary reservoir-bearing cells. The study supports continued investigation of 2-HSB as a compound that may combine the "shock" and "kill" functions within a single molecular entity, but additional experiments—detailed mechanistic studies, broader ex vivo testing, and safety profiling—are required before translational or clinical considerations can be addressed.
The content summarized here derives from the article abstract as presented in PubMed. The abstract reports key findings and high-level mechanistic associations but does not include experimental details such as screening methodology, compound concentrations, the number and type of cell lines tested, quantitative outcomes, or safety assessments. Those methodological and quantitative specifics were not reported in the source material provided and would need to be consulted directly from the full article for comprehensive evaluation.
Keywords emphasized in the source: HIV latency, LRA, Shock and Kill, apoptosis, latent HIV reservoir, tat.